Pinetree Therapeutics has a total of 26 patents globally, out of which 8 have been granted. Of these 26 patents, more than 69% patents are active. The USA is where Pinetree Therapeutics has filed the maximum number of patents, followed by Europe, Australia and Canada. Parallelly, Korea (South) seems to
Combined Therapeutics has a total of 48 patents globally, out of which 7 have been granted. Of these 48 patents, more than 83% patents are active. Europe (EPO) is where Combined Therapeutics has filed the maximum number of patents, followed by USA and Japan. Parallelly, USA seems to be the
Phanes Therapeutics has a total of 246 patents globally, out of which 23 have been granted. Of these 246 patents, more than 83% patents are active. China and Europe (EPO) is where Phanes Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the
Khloris Biosciences has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. United States of America is where Khloris Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States
Kelonia Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kelonia Therapeutics. Kelonia
Cambridge Technologies has a total of 9 patents globally, out of which 4 have been granted. Of these 9 patents, more than 88% patents are active. Mexico, The United States of America and Japan is where Cambridge Technologies has filed the maximum number of patents, followed by Canada and Europe.
Capsida Biotherapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 65% patents are active. Australia and Canada is where Capsida Biotherapeutics has filed the maximum number of patents, followed by Japan, United States of America and Europe.
Spirovant Sciences has a total of 37 patents globally, out of which no patents have been granted. Of these 37 patents, more than 89% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Spirovant Sciences. Spirovant
Tevogen Bio has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 80% patents are active. United States of America is where Tevogen Bio has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States of
Acceligen has a total of 9 patents globally. Of these 9 patents, more than 66% patents are active. United States of America and Australia are where Acceligen has filed the maximum number of patents, followed by Israel and Canada. Parallelly, United States of America seems to be the main focused
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.